新生儿坏死性小肠结肠炎的危险因素
Risk Factors for Neonatal Necrotizing Enterocolitis
DOI: 10.12677/ACM.2022.1281118, PDF,    科研立项经费支持
作者: 樊艳玲, 姜 泓*:延安大学附属医院新生儿科,陕西 延安
关键词: 坏死性小肠结肠炎危险因素Necrotizing Enterocolitis Risk Factors
摘要: 坏死性小肠结肠炎(NEC)主要见于早产儿,是一种严重危害新生儿生命的疾病,也是NICU最常见的肠道急症。在某些方面,NEC是新生儿学研究成功经验的副产品,其中30~40年前无法存活的低胎龄婴儿现在却可以存活。除了发病率和死亡率极高之外,NEC的长期并发症还包括肠狭窄和粘连、胆汁淤积、短肠综合征、生长迟缓和神经发育迟缓。不幸的是,目前在治疗或预防方面仍没有取得太大进展。在检查文献时,人们可能会认为NEC是一个单一的、同质的疾病,但越来越明确的是,NEC是几种不同表现的疾病或表型。并且,目前对于这种疾病的危险因素及病理生理学仍然知之甚少。NEC的危险因素是多样的,不同危险因素有不同的肠坏死途径。自发性肠穿孔、继发于心脏异常的缺血性肠病以及其他与早产儿最常见的NEC形式。许多观察性研究报告了与NEC相关的临床和非临床风险因素,但在延安地区这些危险因素尚不清楚。为了确定NEC这一复杂疾病的独立风险因素,考虑用多变量分析(最好是前瞻性的)队列设计(包括多个协变量)是比较合适的。本综述描述了一些不同危险的NEC,并对其危险因素进行了一些评估,其中遗传因素、肠不成熟、血流动力学不稳定、炎症和生态失调为本综述主要讨论的NEC的危险因素。
Abstract: Necrotizing enterocolitis (NEC) is the most common intestinal emergency in the NICU. In some ways, NEC is a byproduct of the success of neonatology, in which low-gestational age babies that would not have survived 30 or 40 years ago are now viable. In addition to high morbidity and mortality, long-term complications of NEC include: intestinal stricture and adhesions, cholestasis, short bowel syndrome, growth retardation, and neurodevelopmental delay. Unfortunately, there is still not much progress in treatment or prevention. In examining the literature, one might think that NEC is a single, homogenous disease, but it is increasingly clear that NEC is a disease or phenotype with several different manifestations. In addition, the risk factors and pathophysiology of this disease are still poorly understood. Risk factors for NEC are varied, and different risk factors have different pathways of intestinal necrosis. Spontaneous intestinal perforation, ischemic bowel disease sec-ondary to cardiac abnormalities, and other forms of NEC are most commonly associated with prem-ature infants. Many observational studies have reported clinical and non-clinical risk factors associ-ated with NEC, but these written risk factors remain unclear in Yan’an. To determine independent risk factors for this complex disease, it is appropriate to consider a multivariable analysis (prefera-bly prospective) cohort design that includes multiple covariables. This review describes a number of different risk factors for NEC and provides an assessment of their risk factors, among which ge-netic factors, intestinal immaturity, hemodynamic instability, inflammation and ecological disor-ders are discussed.
文章引用:樊艳玲, 姜泓. 新生儿坏死性小肠结肠炎的危险因素[J]. 临床医学进展, 2022, 12(8): 7757-7766. https://doi.org/10.12677/ACM.2022.1281118

参考文献

[1] Yu, J., Zhong, B., Zhao, L., Hou, Y., Wang, X. and Chen, X. (2021) Receptor-Interacting Serine/Threonine-Protein Ki-nase 1 (RIPK1) Inhibitors Necrostatin-1 (Nec-1) and 7-Cl-O-Nec-1 (Nec-1s) Are Potent Inhibitors of NAD(P)H: Qui-none Oxidoreductase 1 (NQO1). Free Radical Biology & Medicine, 173, 64-69. [Google Scholar] [CrossRef] [PubMed]
[2] Wang, K., Tao, G. and Sylvester, K.G. (2019) Recent Advances in Prevention and Therapies for Clinical or Experimental Necrotizing Enterocolitis. Digestive Diseases and Sciences, 64, 3078-3085. [Google Scholar] [CrossRef] [PubMed]
[3] Valpacos, M., Arni, D., Keir, A., Aspirot, A., Wilde, J.C.H., Beasley, S., Karam, O., et al. (2018) Diagnosis and Management of Ecrotizing Enterocolitis: An International Survey of Neonatologists and Pediatric Surgeons. Neonatology, 113, 170-176. [Google Scholar] [CrossRef] [PubMed]
[4] Samuels, N., van de Graaf, R.A., de Jonge, R.C.J., Reiss, I.K.M. and Vermeulen, M.J. (2017) Risk Factors for Necrotizing Enterocolitis in Neonates: A Systematic Review of Prognostic Studies. BMC Pediatrics, 17, Article No. 105. [Google Scholar] [CrossRef] [PubMed]
[5] van der Heide, M., Hulscher, J.B.F., Bos, A.F. and Kooi, E.M.W. (2021) Near-Infrared Spectroscopy as a Diagnostic Tool for Necrotizing Enterocolitis in Preterm Infants. Pediatric Re-search, 90, 148-155. [Google Scholar] [CrossRef] [PubMed]
[6] Kim, J.H. (2019) Role of Abdominal US in Diagnosis of NEC. Clinics in Perinatology, 46, 119-127. [Google Scholar] [CrossRef] [PubMed]
[7] Alsaied, A., Islam, N. and Thalib, L. (2020) Global Incidence of Necrotizing Enterocolitis: A Systematic Review and Meta-Analysis. BMC Pediatrics, 20, Article No. 344. [Google Scholar] [CrossRef] [PubMed]
[8] Zhang, B., Xiu, W., Dai, Y. and Yang, C. (2020) Protective Ef-fects of Different Doses of Human Milk on Neonatal Necrotizing Enterocolitis. Medicine (Baltimore), 99, e22166. [Google Scholar] [CrossRef
[9] Underwood, M.A. (2019) Probiotics and the Prevention of Necrotizing Enterocolitis. Journal of Pediatric Surgery, 54, 405-412. [Google Scholar] [CrossRef] [PubMed]
[10] Thakkar, H.S. and Lakhoo, K. (2016) The Surgical Manage-ment of Necrotising Enterocolitis (NEC). Early Human Development, 97, 25-28. [Google Scholar] [CrossRef] [PubMed]
[11] Terrin, G., Stronati, L., Cucchiara, S. and De Curtis, M. (2017) Serum Markers of Necrotizing Enterocolitis: A Systematic Review. Journal of Pediatric Gastroenterology and Nutrition, 65, e120-e132. [Google Scholar] [CrossRef
[12] Terrin, G., Scipione, A. and De Curtis, M. (2014) Update in Pathogenesis and Prospective in Treatment of Necrotizing Enterocolitis. BioMed Research International, 2014, Article ID: 543765. [Google Scholar] [CrossRef] [PubMed]
[13] Teresa, C., Antonella, D. and de Ville de Goyet, J. (2019) New Nutritional and Therapeutical Strategies of NEC. Current Pediatric Reviews, 15, 92-105. [Google Scholar] [CrossRef] [PubMed]
[14] Teišerskas, J., Bartašienė, R. and Tamelienė, R. (2019) Associations between Red Blood Cell Transfusions and Necrotizing Enterocolitis in Very Low Birth Weight Infants: Ten-Year Data of a Tertiary Neonatal Unit. Medicina (Kaunas), 55, 16. [Google Scholar] [CrossRef] [PubMed]
[15] Tang, L.H., Basturk, O., Sue, J.J. and Klimstra, D.S. (2016) A Practical Approach to the Classification of WHO Grade 3 (G3) Well-Differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas. The American Journal of Surgical Pa-thology, 40, 1192-1202. [Google Scholar] [CrossRef